News tagged with plavix
Study shows experimental drug cuts stroke risk
(AP) -- An experimental drug reduces the stroke risk in patients with irregular heartbeats by more than three times, compared with the popular drug warfarin - but possibly at a cost, according to new research released Sunday.
Medicine & Health / Medications
Aug 30, 2009 |
5 / 5 (1) |
0
Study contradicts reports of problems with blood-thinner
New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.
Medicine & Health / Medications
Aug 29, 2010 |
not rated yet |
0
Plavix may be treatment for dogs at risk of thromboembolic disease
Companion animals that have a long-term need for anticoagulant drug therapies may soon find help in a top-selling antiplatelet drug marketed to humans: clopidogrel, commonly known by the trade-name Plavix.
Jul 14, 2010 |
not rated yet |
0
FDA warning: some patients cannot process Plavix
(AP) -- The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.
Medicine & Health / Medications
Mar 12, 2010 |
4.3 / 5 (3) |
1
Drug ads ineffective for boosting sales, could cost taxpayers: study
US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher.
Nov 23, 2009 |
not rated yet |
0
New Anti-Clotting Medication Not More Effective than Standard Care; Hint of Other Clinical Benefits
(PhysOrg.com) -- Two large studies confirmed that an investigational, reversible anti-clotting medication failed to show greater effectiveness than clopidogrel or a placebo for patients undergoing a procedure to open blocked ...
Medicine & Health / Medications
Nov 17, 2009 |
not rated yet |
0
Newer Anti-Clotting Medication Found to Be More Effective
(PhysOrg.com) -- A large head-to-head study of two anti-clotting medications for heart patients has found that the investigational compound ticagrelor (Brilinta) was more effective at reducing cardiovascular death than the ...
Medicine & Health / Medications
Aug 30, 2009 |
4 / 5 (2) |
0
Researchers identify gene variant linked to effectiveness of plavix
Researchers at the University of Maryland School of Medicine have identified a common gene variant carried by as many as a third of the general population that is believed to play a major role in determining why people do ...
Aug 25, 2009 |
not rated yet |
0
How life-threatening blood clots take hold
When plaques coating blood vessel walls rupture and expose collagen, platelets spring into action to form a blood clot at the damaged site. Now, a new report in the April 17th issue of the journal Cell, a Cell Press public ...
Medicine & Health / Medical research
Apr 16, 2009 |
not rated yet |
0
Study: Plavix plus aspirin helps prevent strokes
(AP) -- Taking the blood thinner Plavix along with aspirin helped prevent strokes and heart attacks in people with a common heartbeat abnormality that puts them at high risk of these problems, doctors reported Tuesday.
Medicine & Health / Medical research
Mar 31, 2009 |
4 / 5 (1) |
0
FDA extends Plavix patent by 6 months to May 2012
(AP) -- The makers of Plavix, the world's second best-selling medication, said Tuesday they will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under a decision by U.S. health regulators.
Medicine & Health / Medications
Jan 25, 2011 |
not rated yet |
1
Bristol-Myers Squibb sees 3Q profit dip 2 percent
(AP) -- Bristol-Myers Squibb Co. posted a slight decline in third-quarter profit Tuesday as its restrained spending was offset by flat sales of its drugs, lower income from its partners and bigger discounts to government ...
Oct 26, 2010 |
not rated yet |
0
FDA says heartburn drugs can interfere with Plavix
(AP) -- Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack ...
Medicine & Health / Medications
Nov 17, 2009 |
not rated yet |
0
Medco plans to compare Plavix, Effient in study
(AP) -- Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world's second-best selling drug, with the newer Effient.
Medicine & Health / Medications
Oct 20, 2009 |
not rated yet |
0
FDA clears Eli Lilly's blood thinner Effient
(AP) -- The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
Medicine & Health / Medications
Jul 10, 2009 |
not rated yet |
0
Clopidogrel
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix, by Sun Pharmaceuticals under the trade name Clopilet, by Ranbaxy Laboratories under the trade name Ceruvin. It works by irreversibly inhibiting a receptor called P2Y12. Adverse effects include hemorrhage.
For more information about Clopidogrel, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
